Trade

with

MannKind Corp
(NASDAQ: MNKD)
AdChoices
5.65
+0.26
+4.82%
After Hours :
5.66
+0.01
+0.18%

Open

5.42

Previous Close

5.39

Volume (Avg)

4.29M (8.10M)

Day's Range

5.33-5.65

52Wk Range

3.80-11.48

Market Cap.

2.27B

Dividend Rate ( Yield )

-

Beta

1.37

Shares Outstanding

402.38M

P/E Ratio (EPS)

-

AdChoices
Fundamentals
  • Key statistics
  • Growth
  • Profitability
  • Financial health
  • Price ratios
  • Trading statistics
  • Management effectiveness
Industry Biotechnology
Highlights
Analyst Recommendation: Outperform
    • Revenue

    • 0

    • Net Income

    • -191.49M

    • Market Cap.

    • 2.27B

    • Enterprise Value

    • -

    • Net Profit Margin %

    • -

    • PEG (Price/Earnings Growth) Ratio

    • -

    • Beta

    • 1.37

    • Forward P/E

    • -526.32

    • Price/Sales

    • -

    • Price/Book Value

    • -46.73

    • Price/Cash flow

    • -15.02

      • EBITDA

      • -155.97M

      • Return on Capital %

      • -102.43

      • Return on Equity %

      • -

      • Return on Assets %

      • -102.43

      • Book Value/Share

      • -0.12

      • Shares Outstanding

      • 402.38M

      • Last Split Factor (Date)

      • -

      • Last Dividend (Ex-Date)

      • -

      • Dividend Declaration Date

      • -

      Analyst Recommendation
      10/21/2014
      Outperform
        • 1 Year Price Target

        • 5.50

        • Credit Rating

        • -

        • Analysts

        • 2

        • EPS Estimate

        • -0.01

        • Cashflow Estimate

        • -0.18

        Morningstar Consensus estimate data
        • Growth Rate (%)

        • Company

        • Industry

          • Sales (Revenue)

            Q/Q (last year)

          • 0.00

          • 40.73

          • Net Income

            YTD/YTD (last year)

          • -

          • 17.04

          • Net Income

            Q/Q (last year)

          • -

          • 98.90

          • Sales (Revenue)

            5-Year Annual Average

          • -

          • 63.43

          • Net Income

            5-Year Annual Average

          • -

          • 10.65

          • Dividends

            5-Year Annual Average

          • -

          • 15.81

          • Profit Margins (%)

          • Company

          • Industry

            • Gross Margin

            • -

            • 82.75

            • Pre-Tax Margin

            • -

            • 39.38

            • Net Profit Margin

            • -

            • 31.33

            • Average Gross Margin

              5-Year Annual Average

            • -

            • 82.99

            • Average Pre-Tax Margin

              5-Year Annual Average

            • -

            • 33.42

            • Average Net Profit Margin

              5-Year Annual Average

            • -

            • 199.05B

            • Financial Ratios

            • Company

            • Industry

              • Debt/Equity Ratio

              • -

              • 0.76

              • Current Ratio

              • 0.38

              • 2.92

              • Quick Ratio

              • 0.35

              • 2.35

              • Interest Coverage

              • -10.34

              • 38.02

              • Leverage Ratio

              • -

              • 2.21

              • Book Value/Share

              • -0.12

              • 4.79

              • Price Ratios

              • Company

              • Industry

                • Current P/E Ratio

                • -8.33

                • 243.90

                • P/E Ratio 5-Year High

                • -17.28

                • 634.30

                • P/E Ratio 5-Year Low

                • -2.36

                • 124.82

                • Price/Sales Ratio

                • -

                • 9.29

                • Price/Book Value

                • -48.08

                • 8.39

                • Price/Cash Flow Ratio

                • -15.02

                • 49.75

                • Key Metrics

                • Company

                  • Shares Short

                    as of -

                  • -

                  • Short Ratio

                    as of -

                  • -

                  • Short % of Float

                    as of -

                  • -

                  • Shares Short

                    prior month

                  • -

                  • Trailing Annual Dividend Yield

                  • -

                  • 5 Year Average Dividend Yield

                  • -

                  • Key Metrics

                  • Company

                    • Payout Ratio

                    • -

                    • Dividend Date

                    • -

                    • Ex-Dividend Date

                    • -

                    • Last Split Factor

                      new per old

                    • -

                    • Last Split Date

                    • -

                    • Key Metrics

                    • Company

                    • Industry

                      • Return on Equity %

                        (5-Year Average)

                      • -

                        (-)

                      • 37.63

                        (27.20)

                      • Return on Assets %

                        (5-Year Average)

                      • -102.43

                        (-73.20)

                      • 17.22

                        (13.81)

                      • Return on Capital %

                        (5-Year Average)

                      • -

                        (-)

                      • 21.78

                        (17.31)

                      • Income/Employee

                      • -

                      • 117.08k

                      • Inventory Turnover

                      • -

                      • 1.48

                      • Asset Turnover

                      • -

                      • 0.55

                      Current Historical
                      Financials
                      • Income Statement
                      • Balance Sheet
                      • Cash Flow
                      Operating Income
                      -169.40M
                      Operating Margin
                      -
                      Total Equity
                      -
                      Retained Earnings
                      -
                      Free Cashflow
                      -
                      Price/Cashflow
                      -15.02
                      Ownership

                      Institutional Ownership

                      44.67%

                      Top 10 Institutions

                      38.20%

                      Mutual Fund Ownership

                      12.23%

                      Float

                      60.45%

                      5% / Insider Ownership

                      1.03%

                      Corporate insiders or major stockholders reporting trading activity in the stock.

                      Top Mutual Fund Owners

                      Top Institutional Owners

                      Mutual Fund Name

                      Institution Name

                      • Mutual Fund Name

                      • Shares Held

                      • % Change

                      • % Outstanding

                      • Fidelity® Select Biotechnology Portfolio

                      •  

                        8,063,306

                      • 0.00

                      • 2.00

                      • iShares Nasdaq Biotechnology

                      •  

                        5,238,791

                      • -1.85

                      • 1.22

                      • Vanguard Small Cap Index

                      •  

                        4,193,462

                      • 3.17

                      • 1.04

                      • Vanguard Total Stock Mkt Idx

                      •  

                        3,906,896

                      • 3.46

                      • 0.97

                      • iShares Russell 2000 (AU)

                      •  

                        3,497,920

                      • -0.90

                      • 0.81

                      • Vanguard Small Cap Growth Index Fund

                      •  

                        2,834,448

                      • 1.21

                      • 0.70

                      • SPDR® S&P Biotech ETF

                      •  

                        2,646,343

                      • 0.00

                      • 0.62

                      • Vanguard Extended Market Index Fund

                      •  

                        2,354,667

                      • 14.08

                      • 0.59

                      • iShares Russell 2000 Growth

                      •  

                        1,629,233

                      • -0.45

                      • 0.38

                      • BlackRock Global Small Cap Fund

                      •  

                        1,323,547

                      • -10.23

                      • 0.33

                      • Institution Name

                      • Shares Held

                      • % Change

                      • % Outstanding

                      • Vanguard Group, Inc.

                      •  

                        14,020,972

                      • +5.67%

                      • 3.57

                      • BlackRock Fund Advisors

                      •  

                        9,624,896

                      • +15.64%

                      • 2.44

                      • Fidelity Management and Research Company

                      •  

                        9,229,268

                      • -7.35%

                      • 2.35

                      • Greywolf Capital Management LP

                      •  

                        6,206,570

                      • +29.88%

                      • 1.58

                      • State Street Corp

                      •  

                        4,846,280

                      • -14.69%

                      • 1.23

                      • BlackRock Advisors LLC

                      •  

                        2,143,055

                      • -10.79%

                      • 0.54

                      • Creative Planning, Inc.

                      •  

                        2,009,230

                      • +0.15%

                      • 0.50

                      • Northern Trust Investments, N.A.

                      •  

                        1,940,756

                      • -5.49%

                      • 0.49

                      Company Profile

                      Sector

                      Healthcare

                      Industry

                      Biotechnology

                      Type

                      Distressed

                      Style

                      Small Growth

                      MannKind Corp a development stage biopharmaceutical company, was incorporated in the state of Delaware on February 14, 1991. The Company is engaged in the discovery, development and commercialization of therapeutic products for disea...moreses such as diabetes. Its product candidate, AFREZZA inhalation powder, is an ultra rapid-acting insulin therapy that is in late-stage clinical investigation for the treatment of adults with type 1 or type 2 diabetes for the control of hyperglycemia. Its other product MKC253, MKC253 is a Technosphere formulation of GLP-1. Results from a phase 1 trial supported the hypothesis that inhalation of MKC253 may be able to simulate the incretin effect that is lost in patients with type 2 diabetes. Products manufactured in the United States and marketed outside the United States ...moreare subject to certain FDA regulations, as well as regulation by the country in which the products are to be sold.lessless

                      Key People

                      Alfred E. Mann

                      CEO/Chairman of the Board/Director

                      Matthew J. Pfeffer

                      CFO/Chief Accounting Officer/Vice President

                      David Thomson,PhD

                      General Counsel/Secretary/Vice President

                      Diane M. Palumbo

                      Vice President, Divisional

                      Juergen A. Martens,PhD

                      Chief Technology Officer/Vice President, Divisional

                      • MannKind Corp

                      • 28903 North Avenue Paine

                      • Valencia, CA 91355

                      • USA.Map

                      • Phone: +1 661 775-5300

                      • Fax: -

                      • mannkindcorp.com

                      Incorporated

                      1991

                      Employees

                      265

                      Send Feedback

                      We appreciate your input!

                      • I'm having trouble signing into my Microsoft account

                      • I’m having problems with the services stripe (Mail, Facebook, etc.)

                      • There is an issue with my weather information

                      • I see an error in the content

                      • Other

                      Please give an overall site rating: